Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations

References

• Abdelbary G, El-Gendy N. (2008). Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech 9:740–7
   PubMed Web of Science ®Google Scholar
• Abdelkader H. (2012). Design and characterisation of niosomes for ocular delivery of naltrexone hydrochloride [PhD]. The University of Auckland
   Google Scholar
• Abdelkader H, Ismail S, Kamal A, Alany R. (2011). Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 100:1833–46
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Kamal A, et al. (2012a). Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen’s egg chorioallantoic membrane and excised bovine cornea models. Int J Pharm 432:1–10
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Kamal H, Ismail S, Alany RG. (2010). Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochem Characterization. Pharmazie 65:811–7
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Wu Z, Al-Kassas R, Alany R. (2012b). Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm 433:142–8
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Garg A, Kaur IP. (2004). Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol 56:1509–17
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52
   PubMed Web of Science ®Google Scholar
• Arora S, Prashar B, Dhamija H, et al. (2012). Niosome: the unique vesicular drug carriers. J Drug Del Ther 2:96–101
   Google Scholar
• Arunothayanun P, Turton JA, Uchegbu IF, Florence AT. (1999). Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. J Pharm Sci 88:34–8
   PubMed Web of Science ®Google Scholar
• Azeem A, Anwer K, Talegaonkar S. (2009). Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 17:671–89
   PubMed Web of Science ®Google Scholar
• Azmin MN, Florence AT, Handjani-Vila RM, et al. (1985). The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol 37:237–42
   PubMed Web of Science ®Google Scholar
• Azmin MN, Florence AT, Handjani-Vila RM, et al. (1986). The effect of niosome and polysorbate 80 on the metabolism and excretion of methotrexate in mouse. J Microencap 3:95–100
   PubMedGoogle Scholar
• Baillie AJ, Coombs GH, Dolan TF, Laurie J. (1986). Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leshmanial drug, sodium stibogluconate. J Pharm Pharmacol 38:502–5
   PubMed Web of Science ®Google Scholar
• Baillie AJ, Florence AT, Hume LR, et al. (1985). The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol 37:863–8
   PubMed Web of Science ®Google Scholar
• Balakrishnana P, Shanmugama S, Lee WS, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8
   PubMedGoogle Scholar
• Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–52
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226–32
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schatzlein A, et al. (1996). The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 18:349–78
   Web of Science ®Google Scholar
• Egelhaaf RM, Epand RF, Maekawa S. (2003). The arrangement of cholesterol in membranes and binding of NAP-22. Chem Phys Lipids 122:33--9
   Google Scholar
• El Maghraby GM, Williams AC. (2009). Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin. Drug Deliv 6:149–63
   PubMed Web of Science ®Google Scholar
• Elsayed M, Cevc G. (2011). The vesicle-to-micelle transformation of phospholipid–cholate mixed aggregates: a state of the art analysis including membrane curvature effects. Biochimica et Biophysica Acta 1808:140–53
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar V, Khalafallah NM. (2007). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1–16
   PubMed Web of Science ®Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, Hadgraft J, Kreuter J, Wilson CG. (1987). A gamma-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles. Int J Pharm 40:81–4
   Web of Science ®Google Scholar
• Florence AT, Baillie AJ. (1989). Non-ionic surfactant vesicles alternatives to liposomes in drug delivery? In: Prescott LE, Nimmo WS, eds. Novel drug delivery and its therapeutic application. San Francisco, CA: John Wiley & Sons Ltd, 281--96
   Google Scholar
• Girigoswami A, Das S, De S. (2006). Fluorescence and dynamic light scattering studies of niosomes-membrane mimetic systems. Spectrochimica Acta A 64:859–66
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82
   PubMed Web of Science ®Google Scholar
• Hashim F, El-Ridy M, Nasr M, Abdallah Y. (2010). Preparation and characterization of niosomes containing ribavirin for liver targeting. Drug Delivery 17:282–7
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:E1–12
   PubMed Web of Science ®Google Scholar
• Hofland HE, Bouwstra JA, Verhoef JC, et al. (1992). Safety aspects of non-ionic surfactant vesicles – a toxicity study related to the physichochmical characteristics of non-ionic surfactants. J Pharm Pharmacol 44:287–94
   PubMed Web of Science ®Google Scholar
• Hofland HEJ, Bouwstra JA, Ponec M, et al. (1991). Interactions of non-ionic surfactant vesicles with cultured keratinocytes and human skin in vitro: a survey of toxicological aspects and ultrastructural changes in stratum corneum. J Contr Rel 16:155–68
   Web of Science ®Google Scholar
• Hunter CA, Dolan TF, Coombs GH, Baillie AJ. (1988). Vesicular system (niosome & liposome) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol 40:161–5
   PubMed Web of Science ®Google Scholar
• Ibrahim AA, Bosela AA, Ahmed SM, Mahrous GM. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Euro J Pharm Biopharm 59:485–90
   PubMed Web of Science ®Google Scholar
• Ingvarsson PT, Yang M, Nielsen HM, et al. (2011). Stabilization of liposomes during drying. Expert Opinion Drug Delivery 8:375–88
   PubMed Web of Science ®Google Scholar
• Israelachvili JN, Marcelja S, Horn RG. (1980). Physical principles of membrane organization. Quart Rev Biophys 13:121–200
   PubMed Web of Science ®Google Scholar
• Israelachvili JN, Mitchell DJ. (1975). A model for the packing of lipids in bilayer membranes. Biochim Biophys Acta 389:13–9
   PubMed Web of Science ®Google Scholar
• Israelachvili JN, Mitchell DJ, Ninham BW. (1976). Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. J Chem Soc Faraday Trans II 72:1525–68
   Web of Science ®Google Scholar
• Jain CP, Vyas SP. (1995). Preparation and characterisation of niosomes containing rifampicin for lung targeting. J Microencap 12:401–7
   PubMed Web of Science ®Google Scholar
• Jain S, Vyas SP. (2006). Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res 16:331–45
   PubMed Web of Science ®Google Scholar
• Junginger HE, Hofland HEJ, Bouwstra JA. (1991). Liposomes and niosomes: interactions with human skin. Cosmet Toilet 106:45–50
   Google Scholar
• Kaur IP, Aggarwal D, Singh H. (2010). Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefe's Archive Clin Experiment Ophthalmol 248:1467–72
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Aggarwal D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm 269:1–14
   PubMed Web of Science ®Google Scholar
• Kaur IP, Rana C, Singh H. (2008). Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther 24:481–93
   PubMed Web of Science ®Google Scholar
• Kim JG, Kim JD. (1991). Vesicle to micelle transitions of egg phosphatidylcholine liposomes induced by nonionic surfactants, poly(oxyethylene) cetyl ethers. J Biochem 110:436–42
   PubMed Web of Science ®Google Scholar
• Kiwada H, Niimura H, Fujisaki Y, et al. (1985). Application of synthetic alkyl glycoside vesicles as drug carriers. I preparation and physical properties. Chem Pharm Bull 33:753–9
   PubMed Web of Science ®Google Scholar
• Lawrence MJ. (2003). Sorbitan esters (sorbitan fatty acid esters). In: Rowe RC, Sheskey PL, Weller PL, eds. Handbook of pharmaceutical excipients. 4th edn. London, UK: Pharmaceutical Press
   Google Scholar
• Manconi M, Valenti D, Sinico C, et al. (2003). Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 260:261–72
   PubMed Web of Science ®Google Scholar
• Manosroi A, Chutoprapat R, Abe M, Manosroi J. (2008a). Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid. Int J Pharm 352:248–55
   PubMed Web of Science ®Google Scholar
• Manosroi A, Jantrawuta P, Manosroi J. (2008b). Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 360:156–63
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces 30:129–38
   Web of Science ®Google Scholar
• Maurer N, Zhigaltsev I, Cullis PR. (2007). Encapsulation of nucleic acid–based therapeutics. In: Gregoriadis G, ed. Liposome technology: entrapment of drugs and other materials into liposomes. 3rd edn. New York: Informa Healthcare, 149--68
   Google Scholar
• Mayer LD, Tai LC, Ko DS, et al. (1989). Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 49:5922–30
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Elmaradny HA, Samaha MW. (2009). Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization. Drug Development Industrial Pharm 35:583–93
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Elmaradny HA, Samaha MW. (2010). Mucoadhesive liposomes as ocular delivery system: physical, microbiological and in vivo assessment. Drug Development Industrial Pharmacy 36:108–18
   PubMed Web of Science ®Google Scholar
• Meisnera D, Mezeib M. (1995). Liposome ocular delivery systems. Adv Drug Delivery Rev 16:75–93
   Web of Science ®Google Scholar
• Moazeni E, Gilani K, Sotoudegan F, et al. (2010). Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul 27:618–27
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Patra B, Layek B, Mukherjee A. (2007). Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study. Int J Nanomedicine 2:213–25
   PubMed Web of Science ®Google Scholar
• Muzzalupo R, Tavano L, Cassano R, et al. (2011). A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur J Pharm Biopharm 79:28–35
   PubMed Web of Science ®Google Scholar
• Nakanoa K, Tozuk Y, Yamamotob H, et al. (2008). A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy. Int J Pham 355:203–9
   PubMed Web of Science ®Google Scholar
• Namdeo A, Jain NK. (1999). Niosomal delivery of 5-fluorouracil. J Microencapsul 16:731–40
   PubMed Web of Science ®Google Scholar
• Naresh RAR, Udupa N. (1996). Niosome encapsulated bleomycin. STP Pharm Sci 6:61–71
   Google Scholar
• Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25:499–512
   PubMed Web of Science ®Google Scholar
• Niemac SM, Ramachandran C, Weiner N. (1995). Influence of non-ionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in-vivo study using hamster ear model. Pharm Res 12:1184–8
   PubMed Web of Science ®Google Scholar
• Ning M, Guo Y, Pan H, et al. (2006). Preparation and characterization of EP-liposomes and Span 40-niosomes. Pharmazie 61:208–212
   PubMed Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
   PubMed Web of Science ®Google Scholar
• Parthasarathi G, Udupa N, Umadevi P, Pillai GK. (1994). Niosome encapsulated of vincristine sulfate-improved anticancer activity with reduced toxicity in mice. J Drug Target 2:173–82
   PubMed Web of Science ®Google Scholar
• Perrie Y, Mohammed AUR, Vangala A, McNeil S. (2007). Environmental scanning electron microscopy offers real-time morphological analysis of liposomes and niosomes. J Liposome Res 17:27--37
   Google Scholar
• Planas ME, Gonzalez P, Rodriguez L, et al. (1992). Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain on sensitivity by anesthetic Liposomes. Anesth. Analg 75:615–21
   PubMed Web of Science ®Google Scholar
• Rajera R, Nagpal K, Singh SK, Mishra DN. (2011). Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull 34:945–53
   PubMed Web of Science ®Google Scholar
• Reddy DN, Udupa N. (1993). Formulation and evaluation of oral and transdermal preparations of flurbiprofen and piroxicam incorporated with different carriers. Drug Dev Ind Pharm 19:843–52
   Web of Science ®Google Scholar
• Saettone MF, Perini G, Carafa M, et al. (1996). Non-ionic surfactant vesicles as ophthalmic carriers for cyclopentolate. A preliminary evaluation. STP Pharma Sci 6:94–8
   Google Scholar
• Sahin NO. (2007). Niosomes as nanocarrier systems. In: Mozafari MR, ed. Nanomaterials and nanosystems for biomedical applications. New York: Springer, 67--81
   Google Scholar
• Schreier H, Bouwstra J. (1994). Liposomes and niosomes as topical drug carriers-dermal and transdermal drug-delivery. J Control Rel 30:1–15
   Web of Science ®Google Scholar
• Shahiwala A, Misra A. (2002). Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharmaceut Sci 5:220–5
   PubMed Web of Science ®Google Scholar
• Shamma RN, Elsayed I. (2013). Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res 23:244–54
   PubMed Web of Science ®Google Scholar
• Solanki AB, Parikh JR, Parikh RH, and Patel MR. (2010). Evaluation of different compositions of niosomes to optimize aceclofenac transdermal delivery. Asian Journal of Pharmaceutical Sciences 5:87–95
   Google Scholar
• Szoka F, Papahadjopoulos D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Ac Sci 75:4194–8
   PubMed Web of Science ®Google Scholar
• Talsma H, Steenbergen MJV, Borchert JCH, Crommelin DJA. (1994). A novel technique for the one-step preparation of liposomes and non-ionic surfactant vesicles without the use of organic solvents. Liposome formation in a continuos gas stream: the bubble method. J Pharm Sci 83:276–80
   PubMed Web of Science ®Google Scholar
• Tanaka M. (1990). Properties of aqueous vesicle dispersion formed with poly(oxyethylene) hydrogenated castor oil. J Am Oil Chem Soc 67:55–60
   Web of Science ®Google Scholar
• Tanford C. (1973). The hydrophobic effect: formation of micelles and biological membranes. New York: John Wiley
   Google Scholar
• Tavano L, Vivacqua M, Carito V, et al. (2013). Doxorubicin loaded magneto-niosomes for targeted drug delivery. Colloids Surfaces B: Biointerfaces 102:803–7
   PubMed Web of Science ®Google Scholar
• Touitou E, Alkabes M, Dayan N. (1997). Ethosomes: novel lipid vesicular system for enhanced delivery. Pharm Res S14:305–6
   Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Rel 65:403–18
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Bouwstra JA, Florence AT. (1992). Large disk-shaped structures (Discomes) in non-ionic surfactant vesicles to micelle transitions. J Phys Chem 96:10548–53
   Web of Science ®Google Scholar
• Uchegbu IF, Double JA, Turton JA, Florence AT. (1995). Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse. Pharm Res 12:1019–24
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Duncan R. (1997). Niosomes containing N-(2 hydroxypropyl)methacrylamide copolymer-doxorubicin (PK1): effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution. Int J Pharm 155:7–17
   Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. (1995). Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 58:1–55
   Web of Science ®Google Scholar
• Uchegbu IF, Gianasi ECF, Florence AT, Duncan R. (1996). Niosome encapsulation of a doxorubicin polymer conjugate. Eur J Pharm Sci 4:S28
   Google Scholar
• Uchegbu IF, Schatzlein AG, Vanlerrberghe G, et al. (1997). Polyhedral non-ionic surfactant vesicles. J Pharm Pharmacol 49:606–10
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
   Web of Science ®Google Scholar
• van Hal D, Vanrensen A, Devringer T, et al. (1996). Diffusion of estradiol from non-ionic surfactant vesicles through human stratum-corneum in vitro. STP Pharma Sci 6:72–8
   Google Scholar
• Varshosaz J, Pardakhty A, Hajhashemi V, Najafabadi AR. (2003). Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv 10:251–62
   PubMed Web of Science ®Google Scholar
• Vora B, Khopade A, Jain N. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Rel 54:149–65
   PubMed Web of Science ®Google Scholar
• Vyas SP, Mysore N, Jaittley V, Venkatesan N. (1998). Discoidal niosome based controlled ocular delivery of Timolol maleate. Pharmazie 53:466–9
   PubMed Web of Science ®Google Scholar
• Wallach DFH. Philippot JR. (1993). New type of lipid vesicle: novasome. In: Gregoriadis G, ed. Liposome Technology. Florida: CRC Press, 141--56
   Google Scholar
• Walter A, Vinson PK, Kaplun A, Talmon Y. (1991). Intermediate structures in the cholate-phosphatidylcholine vesiclemicelle transition. Biophs J 60:1315–25
   PubMed Web of Science ®Google Scholar
• Waraporn S, Boonsri O, Nontima V. (2006). Preparation and characterization of propylthiouracil niosomes. J Liposome Res 16:391–401
   PubMed Web of Science ®Google Scholar
• Waterman KC, Adami RC, Alsante KM, et al. (2002). Stabilization of pharmaceuticals to oxidative degradation. Pharm Dev Technol 7:1–32
   PubMed Web of Science ®Google Scholar
• Yoshioka TBS, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, Span 40, Span 60 and Span 80) and a sorbitsan triester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar
• Zhigaltsev IV, Kaplun AP, Kucheryanu VG, et al. (2001). Liposomes containing dopamine entrapped in response to transmembrane ammonium sulfate gradient as carrier systrem for dopamine delivery into the brain of Parkinsonian mice. J Liposome Res 11:55–71
   PubMed Web of Science ®Google Scholar
• Zuidam NJ, Lee SS, Crommelin DJA. (1993). Sterilization of liposomes by heat treatment. Pharm Res 10:1591–6
   PubMed Web of Science ®Google Scholar
• Zuidam NJ, Winden EV, Vrueh R, Crommelin DJA. (2003). Stability, storage, and sterilization of liposomes. In: Torchilin V, Weissig V, eds. Liposomes: a practical approach. 2nd edn. New York: Oxford University Press, 149--65
   Google Scholar